These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3791557)

  • 1. Protein binding of five platinum compounds. Comparison of two ultrafiltration systems.
    van der Vijgh WJ; Klein I
    Cancer Chemother Pharmacol; 1986; 18(2):129-32. PubMed ID: 3791557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ethanol plasma-protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrations.
    Ma J; Stoter G; Verweij J; Schellens JH
    Cancer Chemother Pharmacol; 1996; 38(4):391-4. PubMed ID: 8674165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative binding of platinum anti-tumour compounds to plasma proteins in the rat (in vivo) and mouse (in vitro).
    Perera A; Jackson H; Sharma HL; McAuliffe CA; Fox BW
    Chem Biol Interact; 1992 Dec; 85(2-3):199-213. PubMed ID: 1493609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of cisplatin and three analogues in mice and humans.
    van Hennik MB; van der Vijgh WJ; Klein I; Elferink F; Vermorken JB; Winograd B; Pinedo HM
    Cancer Res; 1987 Dec; 47(23):6297-301. PubMed ID: 3315183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of storage on the binding of carboplatin to plasma proteins.
    Erkmen K; Egorin MJ; Reyno LM; Morgan R; Doroshow JH
    Cancer Chemother Pharmacol; 1995; 35(3):254-6. PubMed ID: 7805185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of free valproic acid concentrations using the Amicon Micropartition MPS-1 Ultrafiltration System.
    March C; Blanke RV
    Ther Drug Monit; 1985; 7(1):115-20. PubMed ID: 3922094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatographic procedure for the quantitative analysis of carboplatin in beagle dog plasma ultrafiltrate.
    Duncan GF; Faulkner HC; Farmen RH; Pittman KA
    J Pharm Sci; 1988 Mar; 77(3):273-6. PubMed ID: 3286860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Amicon Centrifree micropartition system with the Sartorius SM 13249E Centrisart I device to determine protein free phenytoin concentrations.
    Zysset T; Zeugin T
    Ther Drug Monit; 1986; 8(3):346-51. PubMed ID: 3529518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification and clinical application of carboplatin in plasma ultrafiltrate.
    Downing K; Jensen BP; Grant S; Strother M; George P
    J Pharm Biomed Anal; 2017 May; 138():373-377. PubMed ID: 28260690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay.
    Schroyens W; Dodion P; Rozencweig M
    J Cancer Res Clin Oncol; 1990; 116(4):392-6. PubMed ID: 2202731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disposition of carboplatin in the beagle dog.
    Gaver RC; George AM; Duncan GF; Morris AD; Deeb G; Faulkner HC; Farmen RH
    Cancer Chemother Pharmacol; 1988; 21(3):197-202. PubMed ID: 3282707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro stability, plasma protein binding and blood cell partitioning of 14C-carboplatin.
    Gaver RC; George AM; Deeb G
    Cancer Chemother Pharmacol; 1987; 20(4):271-6. PubMed ID: 3319277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of carboplatin pharmacokinetics between an anephric child and two children with normal renal function.
    Koren G; Weitzman S; Klein J; Moselhy G
    Med Pediatr Oncol; 1993; 21(5):368-72. PubMed ID: 8388075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls in the determination of unbound carbamazepine concentrations in plasma.
    Lohman JJ; Merkus FW; Costongs GM; Hegtermans EP; Hooymans PM
    Pharm Weekbl Sci; 1984 Apr; 6(2):91-5. PubMed ID: 6728640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of carboplatin.
    van der Vijgh WJ
    Clin Pharmacokinet; 1991 Oct; 21(4):242-61. PubMed ID: 1760899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
    Boven E; van der Vijgh WJ; Nauta MM; Schlüper HM; Pinedo HM
    Cancer Res; 1985 Jan; 45(1):86-90. PubMed ID: 4038381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring phenytoin in salivary and plasma ultrafiltrates of pediatric patients.
    Bachmann K; Forney RB; Voeller K
    Ther Drug Monit; 1983; 5(3):325-9. PubMed ID: 6636260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.
    Litterst CL; Gram TE; Dedrick RL; Leroy AF; Guarino AM
    Cancer Res; 1976 Jul; 36(7 PT 1):2340-4. PubMed ID: 1277140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrafiltrable calcium and magnesium in ultrafiltrates of serum prepared with the Amicon MPS-1 system.
    D'Costa M; Cheng PT
    Clin Chem; 1983 Mar; 29(3):519-22. PubMed ID: 6825266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding.
    Elferink F; van der Vijgh WJ; Klein I; Pinedo HM
    Clin Chem; 1986 Apr; 32(4):641-5. PubMed ID: 3513991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.